Literature DB >> 1180299

Radical hysterectomy or radiotherapy for stage I cervical cancer. A prospective comparison with 5 and 10 years follow-up.

M Newton.   

Abstract

A prospective study of the treatment of 119 patients with Stage I carcinoma of the cervix by radical hysterectomy alone (58 patients) or radiotherapy alone (61 patients) was undertaken between Jan. 1, 1956, and May 31, 1966. Eighty-one per cent of the patients treated by radical hysterectomy survived 5 years as compared with 74 per cent of those treated by radiotherapy. The 10 year survival rates were 75 and 65 per cent, respectively. These differences were not statistically significant. Complications of treatment were relatively few except for a greater incidence of urinary tract problems after surgical treatment; most of these were resolved with restoration of normal function. When recurrence occurred in the surgical series further treatment by radiotherapy offered a reasonable prospect of survival. Failure of radiotherapy left relatively little opportunity for later treatment by operation.

Entities:  

Mesh:

Year:  1975        PMID: 1180299     DOI: 10.1016/0002-9378(75)90041-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  10 in total

Review 1.  Management of gynaecological cancers.

Authors:  A Melville; A Eastwood; J Kleijnen; H Kitchener; P Martin-Hirsch; L Nelson
Journal:  Qual Health Care       Date:  1999-12

2.  [Radical surgery or radical radiotherapy in patients with stage Ib and IIa cervix carcinoma].

Authors:  H Sack
Journal:  Strahlenther Onkol       Date:  1998-08       Impact factor: 3.621

3.  Clinical determinants of survival from stage Ib cervical cancer in an inner-city hospital.

Authors:  W W Thoms; E R Unger; R Carisio; R Nisenbaum; C O Spann; I R Horowitz; W C Reeves
Journal:  J Natl Med Assoc       Date:  1998-05       Impact factor: 1.798

4.  The impact of close surgical margins after radical hysterectomy for early-stage cervical cancer.

Authors:  Georgia A McCann; Susanne K Taege; Christina E Boutsicaris; Gary S Phillips; Eric L Eisenhauer; Jeffrey M Fowler; David M O'Malley; Larry J Copeland; David E Cohn; Ritu Salani
Journal:  Gynecol Oncol       Date:  2012-11-05       Impact factor: 5.482

Review 5.  Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix.

Authors:  Astrid Baalbergen; Yerney Veenstra; Lukas Stalpers
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

6.  Radiation-sparing managements for cervical cancer: a developing countries perspective.

Authors:  Myrna Candelaria; Lucely Cetina; Alicia Garcia-Arias; Carlos Lopez-Graniel; Jaime de la Garza; Elizabeth Robles; Alfonso Duenas-Gonzalez
Journal:  World J Surg Oncol       Date:  2006-11-13       Impact factor: 2.754

7.  High-Dose-Rate Intracavitary Brachytherapy Under Conscious Sedation a Viable Practical Alternative to Spinal Anaesthesia in Carcinoma Cervix: A Retrospective Study in a Tertiary Care Centre in Eastern India.

Authors:  Bikash Ranjan Mahapatra; Bijay K Barik; Anupam Muraleedharan; Avinash Badajena; Adhar Amritt; Satyabrata Kanungo; Ashutosh Pattanaik; Minakshi Mishra; Sovan S Dhar; Sandip K Barik; Saroj Kumar Das Majumdar; Dillip Kumar Parida
Journal:  Cureus       Date:  2021-11-30

Review 8.  Surgical treatment of stage IA2 cervical cancer.

Authors:  Fani Kokka; Andrew Bryant; Elly Brockbank; Arjun Jeyarajah
Journal:  Cochrane Database Syst Rev       Date:  2014-05-29

9.  A patient derived xenograft model of cervical cancer and cervical dysplasia.

Authors:  Luke I Larmour; Fiona L Cousins; Julie A Teague; James A Deane; Tom W Jobling; Caroline E Gargett
Journal:  PLoS One       Date:  2018-10-26       Impact factor: 3.240

10.  Long-Term Toxicity and Efficacy of Intensity-Modulated Radiation Therapy in Cervical Cancers: Experience of a Cancer Hospital in Pakistan.

Authors:  Muhammad Atif Mansha; Tabinda Sadaf; Asmara Waheed; Amna Munawar; Asma Rashid; Samreen Javed Chaudry
Journal:  JCO Glob Oncol       Date:  2020-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.